TY  - JOUR
AU  - Saro, Cristina
AU  - Ceballos, Daniel
AU  - Muñoz, Fernando
AU  - de la Coba, Cristóbal
AU  - Aguilar, Maria Dolores
AU  - Lazaro, Pablo
AU  - Garcia-Sanchez, Valle
AU  - Hernandez, Mariola
AU  - Barrio, Jesus
AU  - de Francisco, Ruth
AU  - Fernandez, Luis I
AU  - Barreiro-de Acosta, Manuel
PY  - 2016
DO  - 10.17235/reed.2016.4600/2016
SN  - 1130-0108
UR  - http://hdl.handle.net/10668/10716
T2  - Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva
AB  - Clinical trials have shown the efficacy of adalimumab in Crohn's disease, but the outcome in regular practice remains unknown. The aim of the study was to examine clinical status, quality of life, and work productivity of Crohn's disease patients...
LA  - en
PB  - Sociedad Española de Patologia Digestiva
KW  - Adalimumab
KW  - Adult
KW  - Aged
KW  - Crohn disease
KW  - Efficiency
KW  - Female
KW  - Follow-up studies
KW  - Humans
KW  - Immunosuppressive agents
KW  - Male
KW  - Middle aged
KW  - Prospective studies
KW  - Quality of life
KW  - Treatment outcome
KW  - Work
KW  - Young adult
TI  - Clinical status, quality of life, and work productivity in Crohn's disease patients after one year of treatment with adalimumab.
TY  - research article
VL  - 109
ER  -